1 May 2023 true No description of principal activity Taxfiler 2024.6 13339212business:CompanyLimitedByGuarantee2023-05-012024-04-30 133392122023-04-30 13339212business:EntityNoLongerTradingButTradedInPast2023-05-012024-04-30 133392122023-05-012024-04-30 13339212business:AuditExempt-NoAccountantsReport2023-05-012024-04-30 13339212business:FilletedAccounts2023-05-012024-04-30 133392122024-04-30 13339212business:Director12023-05-012024-04-30 13339212business:RegisteredOffice2023-05-012024-04-30 133392122023-04-30 13339212core:PreviouslyStatedAmount2024-04-30 13339212core:PreviouslyStatedAmount2023-04-30 13339212business:SmallEntities2023-05-012024-04-30 13339212countries:EnglandWales2023-05-012024-04-30 133392122022-05-012023-04-30 iso4217:GBP xbrli:pure
Company Registration No. 13339212 (England and Wales)
AME BLOOD CANCER TRUST Unaudited accounts for the year ended 30 April 2024
AME BLOOD CANCER TRUST Unaudited accounts Contents
Page
- 2 -
AME BLOOD CANCER TRUST Company Information for the year ended 30 April 2024
Director
NAQVI, Sheeraz Ali
Company Number
13339212 (England and Wales)
Registered Office
23A DUDDEN HILL LANE LONDON NW10 2ET UNITED KINGDOM
Accountants
M A Associates 21a Dudden Hill Lane London NW10 2ET
- 3 -
AME BLOOD CANCER TRUST Statement of financial position as at 30 April 2024
2024 
2023 
Notes
£ 
£ 
Net current assets
- 
- 
Net assets
- 
- 
Members' funds
- 
- 
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 January 2025 and were signed on its behalf by
NAQVI, Sheeraz Ali Director Company Registration No. 13339212
- 4 -
AME BLOOD CANCER TRUST Notes to the Accounts for the year ended 30 April 2024
1
Statutory information
AME BLOOD CANCER TRUST is a private company, limited by guarantee, registered in England and Wales, registration number 13339212. The registered office is 23A DUDDEN HILL LANE, LONDON, NW10 2ET, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Company limited by guarantee
The company is limited by guarantee and has no share capital. Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.
5
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 5 -